BCTX   $0.8  -2.44% Market Closed After Close 0.809 1.13%

Briacell Therapeutics Corp
Total Cash 935.69K
totalCashPerShare 0.051
EBITDA -35.25M
Total Debt 0.00
quickRatio 0.141
currentRatio 0.818
Total Revenue
debtToEquity
Revenue/Share
ROA -1.2271299
ROE
grossProfits
freeCashflow -17.95M
operatingCashflow -31.01M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 15.25M
forwardPE -0.91119564
floatShares 15.09M
sharesOutstanding 35.84M
sharesShort 449.19K
sharesShortPriorMonth 254.15K
dateShortInterest
sharesPercentSharesOut 0.01%
heldPercentInsiders 0.08%
heldPercentInstitutions 0.13%
Short Ratio help_outline 0.04%
shortPercentOfFloat 0.02%
impliedSharesOutstanding
bookValue -0.373
Price To Book help_outline
earningsQuarterlyGrowth
netIncomeToCommon -6.00M
trailingEps -0.37%
forwardEps -0.92%
enterpriseToEbitda -0.43
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.52 3Q 2024
institutionsCount 26
lastUpdated Oct. 16, 2024, 11:53 p.m.